<?xml version="1.0" encoding="utf-8"?>
<doi_batch xmlns="http://www.crossref.org/schema/4.3.6" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1" xmlns:ai="http://www.crossref.org/AccessIndicators.xsd" xmlns:fr="http://www.crossref.org/fundref.xsd" version="4.3.6" xsi:schemaLocation="http://www.crossref.org/schema/4.3.6 https://www.crossref.org/schemas/crossref4.3.6.xsd">
  <head>
    <doi_batch_id>_1778830039</doi_batch_id>
    <timestamp>20260515072719000</timestamp>
    <depositor>
      <depositor_name>Editor</depositor_name>
      <email_address>editor.jddt@gmail.com</email_address>
    </depositor>
    <registrant>Universal Journal of Pharmaceutical Research</registrant>
  </head>
  <body>
    <journal>
      <journal_metadata>
        <full_title>Universal Journal of Pharmaceutical Research</full_title>
        <abbrev_title>Univ J Pharm Res</abbrev_title>
        <issn media_type="electronic">2456-8058</issn>
        <issn media_type="print">2831-5235</issn>
      </journal_metadata>
      <journal_issue>
        <publication_date media_type="online">
          <month>05</month>
          <day>15</day>
          <year>2026</year>
        </publication_date>
      </journal_issue>
      <journal_article xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1" xmlns:ai="http://www.crossref.org/AccessIndicators.xsd" publication_type="full_text" metadata_distribution_opts="any">
        <titles>
          <title>SOLUBILITY ENHANCEMENT OF SELEXIPAG BY β-CYCLODEXTRIN INCLUSION COMPLEXES</title>
        </titles>
        <contributors>
          <person_name contributor_role="author" sequence="first">
            <surname>Celse Kwitonda</surname>
          </person_name>
          <person_name contributor_role="author" sequence="additional">
            <surname>Sonam Choki</surname>
          </person_name>
          <person_name contributor_role="author" sequence="additional">
            <surname>Kule Gift Diadone</surname>
          </person_name>
        </contributors>
        <jats:abstract xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1">
          <jats:p>Background: Selexipag is an oral, non-prostanoid IP receptor agonist used in treating pulmonary arterial hypertension (PAH). Selexipag has poor aqueous solubility, especially in acidic solution medium. Hence, for the purposes of overcoming solubility limitations associated with selexipag, various techniques such as complexation with appropriate complexing agents have been considered. Cyclodextrins are unique molecules that are cyclic carbohydrates that have been shown to be suitable for the purpose of inclusion complex formation. This is because they form inclusion complexes when combined with insoluble drugs.
Method: The inclusion complex between Selexipag and β-cyclodextrin was prepared using kneading method.
Result: The ability of β-cyclodextrin to increase the solubility of Selexipag has been shown from the results indicating that β-cyclodextrin improves significantly both the solubility and dissolution of selexipag which is a poorly soluble drug. The formation of the inclusion complex was further confirmed using UV-visible spectrophotometry and Fourier transform infrared spectroscopy. In addition, dissolution studies indicated improved dissolution behavior of the complexed drug.
Conclusion: From the results obtained above, β-cyclodextrin appears to be very efficient carrier agent for poorly soluble drugs such as Selexipag which belong to BCS class II.
                 
Peer Review History: 
Received 22 February 2026;   Reviewed 9 March 2026; Accepted  17 April; Available online 15 May 2026
Academic Editor: Dr. Ali Abdullah Al-yahawi, Al-Razi university, Department of Pharmacy, Yemen, alyahawipharm@yahoo.com
Reviewers:
Dr. Mrinal Kanti Bhoumik, Jubilant Cadista Pharmaceutical Inc., mrinal_bhoumik@yahoo.com 
Dr. Ahmed Tagelsir Mohamed Ali, National University, Sudan, ahmedtagelsir7@hotmail.com</jats:p>
        </jats:abstract>
        <publication_date media_type="online">
          <month>05</month>
          <day>15</day>
          <year>2026</year>
        </publication_date>
        <fr:program name="fundref"/>
        <ai:program xmlns:ai="http://www.crossref.org/AccessIndicators.xsd" name="AccessIndicators">
          <ai:license_ref>http://creativecommons.org/licenses/by-nc/4.0</ai:license_ref>
        </ai:program>
        <doi_data>
          <doi>10.22270/ujpr.v11i2.1529</doi>
          <resource>https://ujpronline.com/index.php/journal/article/view/1529</resource>
          <collection property="crawler-based">
            <item crawler="iParadigms">
              <resource>https://ujpronline.com/index.php/journal/article/download/1529/2121</resource>
            </item>
          </collection>
          <collection property="text-mining">
            <item>
              <resource mime_type="application/pdf">https://ujpronline.com/index.php/journal/article/download/1529/2121</resource>
            </item>
            <item>
              <resource mime_type="text/xml">https://ujpronline.com/index.php/journal/article/download/1529/2122</resource>
            </item>
            <item>
              <resource mime_type="text/html">https://ujpronline.com/index.php/journal/article/download/1529/2148</resource>
            </item>
          </collection>
        </doi_data>
      </journal_article>
    </journal>
  </body>
</doi_batch>
